Efficacy and Safety of the Biosimilar Natalizumab PB006 in Comparison to Tysabri®

NCT04115488 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

265

Enrollment

INDUSTRY

Sponsor class

Conditions

Relapsing-Remitting Multiple Sclerosis (RRMS)

Interventions

BIOLOGICAL: Intravenous (IV) infusions

Sponsor

Polpharma Biologics S.A.